FEMALE SEXUAL DYSFUNCTION
| Autor: | Dadak Christian, Bayerle-Eder Michaela |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Libido
Embryology business.industry Female sexual dysfunction Obstetrics and Gynecology Gynecology and obstetrics Affect (psychology) medicine.disease Menopause Distress female sexual dysfunction FEMALE SEXUAL DYSFUNCTION OGASMS DISORDERS FLIBANSERIN НАРУШЕНИЕ СЕКСУАЛЬНОЙ ФУНКЦИИ У ЖЕНЩИН НАРУШЕНИЯ ОРГАЗМА ФЛИБАНСЕРИН Reproductive Medicine RG1-991 medicine Flibanserin Psychological strain flibanserin business ogasms disorders Clinical psychology medicine.drug |
| Zdroj: | Акушерство, гинекология и репродукция, Vol 9, Iss 4, Pp 86-88 (2016) |
| ISSN: | 2313-7347 |
| DOI: | 10.17749/2070-4968.2015.9.4.086-088 |
| Popis: | Female sexual dysfunction affect up to 43% of women causing a "distress" or a psychological strain for the patients. A variety of chronic diseases in addition to menopause and different drugs represents the risk factors to a female sexual dysfunction. Since 2015 the FDA has approved Flibanserin for the treatment of female libido although several other drugs have been proven efficacious. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|